Physician profile
Macdaline Scott
NPI 1750040184
$6,330.55
in general payments reported to CMS, 2019-2025
14 companies · $2,998 in 2025
The $2,998 reported for 2025 was more than what 96% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $528 · 2023: $1,276 · 2024: $1,528 · 2025: $2,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,611 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,610.77 |
| Education | $191.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,128.30 | 2022-2025 | Invega Sustenna, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $908.17 | 2022-2025 | Uzedy, Austedo Xr, Austedo |
| Otsuka America Pharmaceutical, INC. | $791.22 | 2022-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Abbvie INC. | $697.17 | 2022-2025 | |
| Alkermes, INC. | $673.92 | 2022-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $493.02 | 2022-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $444.10 | 2022-2025 | Fanapt, Hetlioz |
| Lundbeck LLC | $374.58 | 2023-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $265.53 | 2023-2025 | Trintellix |
| Neurocrine Biosciences, INC. | $247.09 | 2023-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $159.50 | 2024-2025 | Cobenfy |
| Indivior INC. | $89.48 | 2023-2024 | Perseris |
| Tempus Ai, INC | $35.97 | 2024 | |
| Braeburn INC. | $22.50 | 2025 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Macdaline Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.